NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Lockton said Friday it will build a new global headquarters complex in Leawood, Kansas, part of the Kansas City metropolitan area.Read More
